\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesThe Strategic Research and Innovation Agenda (SRIA) on pandemic preparedness is now open for public consultation. This document will guide the future European Partnership for Pandemic Preparedness, addressing research gaps and setting clear priorities for action.
Researchers, policymakers, stakeholders and the broader community are invited to review the draft SRIA and share their insights.
The consultation is open until 15 December 2024 (8 pm CEST).
Read the draft here: https://beready4pandemics.eu/sria
Access the survey here:
https://ec.europa.eu/eusurvey/runner/Public_Consultation_SRIA_PandemicPreparedness
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space EIT Deployment: Best use of technologies
The Co-Creation Accelerator is a programme run by 28DIGITAL (formerly EIT Digital). It brings together start-ups and industry partners to co-develop solutions to real-world challenges, with a focus on: Validating core technology (TRL 4-5 and above) Strengthening problem-solution fit Reducing technical and market uncertainty Building a cle... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
